Nucleus-specific alteration of raphe neurons in human neurodegenerative disorders

NeuroReport

Volumn 14, Issue 1, 2003, Pages 73-76

  Kovacs, Gabor G ^a,c   Klöppel, Stefan ^a   Fischer, Ingeborg ^a   Dorner, Suzanne ^a   Lindeck Pozza, Elisabeth ^a   Birner, Peter ^b   Bötefür, Ingolf C ^d   Pilz, Peter ^d   Volk, Benedikt ^d   Budka, Herbert ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b UNIVERSITY OF VIENNA   (Austria)

^c SEMMELWEIS UNIVERSITY OF MEDICINE   (Hungary)

^d NONE

Author keywords

Alzheimer's disease; Multiple system atrophy; Parkinson's disease; Progressive supranuclear palsy; Serotonin

Indexed keywords

ALPHA SYNUCLEIN; MONOCLONAL ANTIBODY; TAU PROTEIN; TRYPTOPHAN HYDROXYLASE;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; BRAIN ATROPHY; CLINICAL ARTICLE; CONTROLLED STUDY; DEGENERATIVE DISEASE; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MEDULLA OBLONGATA; NEUROLOGIC DISEASE; NEUROPATHOLOGY; PARKINSON DISEASE; PONS; PRIORITY JOURNAL; PROGRESSIVE SUPRANUCLEAR PALSY; SEROTONINERGIC SYSTEM;

AGED; ALPHA-SYNUCLEIN; ALZHEIMER DISEASE; FEMALE; HUMANS; MALE; MEDULLA OBLONGATA; MIDDLE AGED; MULTIPLE SYSTEM ATROPHY; NERVE TISSUE PROTEINS; NEURODEGENERATIVE DISEASES; NEURONS; PARKINSON DISEASE; PHOSPHORYLATION; PONS; PROTEIN PROCESSING, POST-TRANSLATIONAL; RAPHE NUCLEI; SEROTONIN; SUPRANUCLEAR PALSY, PROGRESSIVE; SYNUCLEINS; TAU PROTEINS; TRYPTOPHAN HYDROXYLASE;

EID: 0037454949     PISSN: 09594965     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001756-200301200-00014     Document Type: Article

References (25)

1. Parent A. Brainstem and cerebellum. In: Parent A (ed). Carpenter's Human Neuroanatomy, 9th edn. Baltimore: Williams and Wilkins; 1996, pp. 421-629.
2. Goedert M, Spillantini MG and Davies SW. Curr Opin Neurobiol 8, 619-632 (1998).
3. Plazzi G, Corsini R, Provini F et al. Neurology 48, 1094-1097 (1997).
4. Aldrich MS, Foster NL, White RF et al. Ann Neurol 25, 577-581 (1989).
5. Poewe W and Hogl B. Curr Opin Neurol 13, 423-426 (2000).
6. Schmidt BJ and Jordan LM. Brain Res Bull 53, 689-710 (2000).
7. Meltzer CC, Smith G, DeKosky ST et al. Neuropsychopharmacology 18, 407-430 (1998).
8. Halliday GM, McCann HL, Pamphlett R et al. Acta Neuropathol (Berl) 84, 638-650 (1992).
9. Chen CE Eastwood SL, Hope T et al. Neuropathol Appl Neurobiol 26, 347-355 (2000).
10. Chinaglia G, Landwehrmeyer B, Probst A et al. Neuroscience 54, 691-699 (1993).
11. Pascual J, Figols J, Grijalba B et al. J Neural Transm Suppl 42, 247-260 (1994).
12. Kish SJ, Chang LJ, Mirchandani L et al. Ann Neurol 18, 530-536 (1985).
13. Sawada M, Nagatsu T, Nagatsu I et al. J Neural Transm 62, 107-115 (1985).
14. Hornykiewicz O and Shannak K. J Neural Transm Suppl 42, 219-227 (1994).
15. Halliday GM, Li YW, Blumbergs PC et al. Ann Neurol 27, 373-385 (1990).
16. Polinsky RJ, Brown RT, Burns RS et al. J Neurol Neurosurg Psychiatry 51, 914-919 (1988).
17. Wiklund L, Leger L and Persson M. J Comp Neurol 203, 613-647 (1981).
18. Wanschitz J, Kloppel S, Jarius C et al. Ann. Neurol 48, 788-791 (2000).
19. Kloppel S, Kovacs GG, Voigtlander T et al. Neuroreport 12, 669-671 (2001).
20. Braak H and Braak E. J Neurol 247 Suppl 2, II3-II10 (2000).
21. Jacobs BL and Fornal CA. Curr Opin Neurobiol 7, 820-825 (1997).
22. Benarroch EE. Mayo Clin Proc 68, 988-1001 (1993).
23. Holmes CJ and Jones BE. Neuroscience 62, 1179-1200 (1994).
24. Braak H, Rub U, Sandmann-Keil D et al. Acta Neuropathol (Berl) 99, 489-495 (2000).
25. Rub U, Del Tredici K, Schultz C et al. Neuropathol Appl Neurobiol 26, 553-567 (2000).